Publication Date
| In 2025 | 0 |
| Since 2024 | 0 |
| Since 2021 (last 5 years) | 0 |
| Since 2016 (last 10 years) | 0 |
| Since 2006 (last 20 years) | 1 |
Descriptor
| Drug Therapy | 17 |
| Hyperactivity | 17 |
| Minimal Brain Dysfunction | 17 |
| Learning Disabilities | 10 |
| Exceptional Child Research | 6 |
| Children | 5 |
| Medical Services | 5 |
| Drug Use | 3 |
| Neurological Impairments | 3 |
| Physicians | 3 |
| Stimulants | 3 |
| More ▼ | |
Source
Author
Publication Type
| Journal Articles | 3 |
| Reports - Research | 2 |
| Information Analyses | 1 |
| Opinion Papers | 1 |
| Speeches/Meeting Papers | 1 |
Education Level
Audience
Location
| Vermont | 1 |
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Direct linkBarkley, Russell A. – Journal of Attention Disorders, 2011
Dr. Goldstein continues the laudable practice of reprinting articles of historical significance in the history of ADHD with this selective reprinting of material from the original article by Maurice Laufer, Eric Denhoff, and Gerald Solomons on hyperkinetic impulsive disorder (HID) in children. This article on HID is among the first articles to…
Descriptors: Attention Span, Minimal Brain Dysfunction, Behavior Disorders, Attention Deficit Hyperactivity Disorder
Peer reviewedEisenberg, Leon – Pediatrics, 1972
Descriptors: Drug Therapy, Drug Use, Exceptional Child Education, Hyperactivity
Peer reviewedComly, Hunter H. – Journal of Learning Disabilities, 1971
Descriptors: Behavior Patterns, Drug Therapy, Exceptional Child Research, Hyperactivity
Peer reviewedHartlage, Lawrence C.; Telzrow, Cathy Fultz – Journal of Research and Development in Education, 1982
Hyperactivity is defined, and the relationships among minimal brain dysfunction, cerebral stimulants, and student characteristics such as activity level, attention and learning, and behavior are discussed. Hyperactive children's responses to the use of Ritalin and methylphenidate are reported. (CJ)
Descriptors: Attention, Drug Therapy, Hyperactivity, Minimal Brain Dysfunction
Peer reviewedFreeman, Roger D. – School Review, 1976
Develops an analysis of what is known about the etiology of hyperkinesis and what is known about the use of stimulant drugs for its treatment. Points out the ambiguities and confusions in diagnosis and treatment calling for an examination of the social and ideological influences upon the medical diagnosis and treatment of hyperkinesis. (Editor/RK)
Descriptors: Drug Therapy, Educational Research, Hyperactivity, Learning Disabilities
Peer reviewedWeber, Bruce A.; Sulzbacher, Stephen I. – Journal of Learning Disabilities, 1975
Averaged electroencephalic audiometry (AEA) was conducted to evaluate the hearing of 12 children (mean age 8 years 6 months) diagnosed as having minimal brain dysfunction (MBD). (Author)
Descriptors: Auditory Tests, Children, Drug Therapy, Exceptional Child Research
Peer reviewedPage, John G.; And Others – Journal of Learning Disabilities, 1974
A controlled, double-blind study used the drug pemoline or a placebo in the management of hyperkinetic behavior with 413 children between 6 and 12 years of age diagnosed as having minimal brain dysfunction. (Author/DB)
Descriptors: Children, Drug Therapy, Evaluation, Exceptional Child Research
Education Digest: Essential Readings Condensed for Quick Review, 1972
Condensed from a report of a 1971 conference sponsored by the U.S. Office of Child Development and the U.S. Office of the Assistant Secretary for Health and Scientific Affairs. (Editor)
Descriptors: Behavior Problems, Drug Therapy, Drug Use, Hyperactivity
Peer reviewedLadd, Edward T. – National Elementary Principal, 1971
The use of drugs to modify child behavior disorders and the risks involved are discussed. Safeguards are suggested to protect children. (A related article is EA 501 452.) (MF)
Descriptors: Behavior Problems, Drug Therapy, Dyslexia, Hyperactivity
Download full textConners, C. Keith – 1971
The study compared the efficacy, side effects, and safety of magnesium pemoline (Cylert) and destroamphetamine (Dexedrine) as compared with placebo. Subjects were 81 children, ages 6-12 years, who evidenced one or more signs of minimal brain dysfunction, and were referred with major complaints of hyperactivity, short attention span,…
Descriptors: Behavior Change, Drug Therapy, Exceptional Child Research, Hyperactivity
Peer reviewedArnold, L. Eugene; And Others – Journal of Learning Disabilities, 1978
The differential effect of amphetamine optical isomers on Bender Gestalt performance was examined in 31 hyperkinetic minimally brain dysfunctioned children between the ages of 4 and 12 years, using a double-blind Latin-square crossover comparison. (Author)
Descriptors: Behavior, Children, Drug Therapy, Exceptional Child Research
Kappelman, Murray M. – Medical Digest, 1976
Available from: Medical Digest, A.S. O'Connor & Company Limited, 26 Sheen Park, Richmond, Surrey, England.
Descriptors: Child Role, Drug Therapy, Hyperactivity, Learning Disabilities
Growth of Hyperkinetic Children Taking Methylphenidate, Dextroamphetamine, or Imipramine/Desipramine
Peer reviewedGross, Mortimer D. – Pediatrics, 1976
Descriptors: Body Height, Body Weight, Child Development, Drug Therapy
Peer reviewedConners, C. Keith; Delamater, Alan – Perceptual and Motor Skills, 1980
Two studies of a visual-motor tracking task purported to effectively discriminate subtypes of minimal brain dysfunction are presented. Subjects were psychiatric inpatients, hyperactive males, and normal controls. The tracking task was found to be a useful measure of stimulant drug action but not of specific hyperkinetic defects. (Author/SJL)
Descriptors: Children, Diagnostic Tests, Drug Therapy, Eye Hand Coordination
Peer reviewedLoney, Jan; Ordona, Truce T. – American Journal of Orthopsychiatry, 1975
Descriptors: Behavior Change, Children, Drug Therapy, Exceptional Child Research
Previous Page | Next Page ยป
Pages: 1 | 2
